{"id":"https://openalex.org/W4415200093","doi":"https://doi.org/10.1093/rheumatology/keaf536","title":"Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study","display_name":"Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study","publication_year":2025,"publication_date":"2025-10-13","ids":{"openalex":"https://openalex.org/W4415200093","doi":"https://doi.org/10.1093/rheumatology/keaf536","pmid":"https://pubmed.ncbi.nlm.nih.gov/41092316","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12862366"},"language":"en","primary_location":{"id":"doi:10.1093/rheumatology/keaf536","doi":"https://doi.org/10.1093/rheumatology/keaf536","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/keaf536","pdf_url":"https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf536/64711702/keaf536.pdf","source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf536/64711702/keaf536.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074816204","display_name":"Minghui Zhao","orcid":"https://orcid.org/0000-0003-2732-5721","observed_orcids":["https://orcid.org/0000-0003-2732-5721","https://orcid.org/0009-0000-8512-0869"]},"institutions":[{"id":"https://openalex.org/I4210130930","display_name":"Peking University First Hospital","ror":"https://ror.org/02z1vqm45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210130930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ming-hui Zhao","raw_affiliation_strings":["Renal Division, Peking University First Hospital, Peking University Institute of Nephrology , Beijing,","Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Division, Peking University First Hospital, Peking University Institute of Nephrology , Beijing,","institution_ids":["https://openalex.org/I4210130930"]},{"raw_affiliation_string":"Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China","institution_ids":["https://openalex.org/I4210130930"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Fidencio Cons Molina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fidencio Cons Molina","raw_affiliation_strings":["Centro de Investigaci\u00f3n en Artritis y Osteoporosis , Mexicali,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n en Artritis y Osteoporosis , Mexicali,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067960810","display_name":"Gustavo Aroca","orcid":"https://orcid.org/0000-0002-9222-3257","observed_orcids":["https://orcid.org/0000-0002-9222-3257"]},"institutions":[{"id":"https://openalex.org/I4210132036","display_name":"Universidad Sim\u00f3n Bol\u00edvar","ror":"https://ror.org/02njbw696","country_code":"CO","type":"education","lineage":["https://openalex.org/I4210132036"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Gustavo Aroca","raw_affiliation_strings":["Renal Division, Simon Bolivar University , Barranquilla,","Renal Division, Simon Bolivar University , Clinica de la Costa, Barranquilla,","Renal Division, Simon Bolivar University, Clinica de la Costa, Barranquilla, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Division, Simon Bolivar University , Barranquilla,","institution_ids":["https://openalex.org/I4210132036"]},{"raw_affiliation_string":"Renal Division, Simon Bolivar University , Clinica de la Costa, Barranquilla,","institution_ids":["https://openalex.org/I4210132036"]},{"raw_affiliation_string":"Renal Division, Simon Bolivar University, Clinica de la Costa, Barranquilla, Colombia","institution_ids":["https://openalex.org/I4210132036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075515457","display_name":"Maria G. Tektonidou","orcid":"https://orcid.org/0000-0003-2238-0975","observed_orcids":["https://orcid.org/0000-0003-2238-0975"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Maria G Tektonidou","raw_affiliation_strings":["Rheumatology Unit, Joint Academic Rheumatology Program, First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens , Athens,","Rheumatology Unit, Joint Academic Rheumatology Program, First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece"],"raw_orcid":"https://orcid.org/0000-0003-2238-0975","affiliations":[{"raw_affiliation_string":"Rheumatology Unit, Joint Academic Rheumatology Program, First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens , Athens,","institution_ids":["https://openalex.org/I200777214"]},{"raw_affiliation_string":"Rheumatology Unit, Joint Academic Rheumatology Program, First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003777359","display_name":"Anubhav N. Mathur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anubhav Mathur","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation , East Hanover, NJ,","Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation , East Hanover, NJ,","institution_ids":[]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120005293","display_name":"Radhika Tangadpalli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090302","display_name":"Novartis (India)","ror":"https://ror.org/00dhvr506","country_code":"IN","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210090302"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Radhika Tangadpalli","raw_affiliation_strings":["Novartis Healthcare Private Limited , Hyderabad,","Novartis Healthcare Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Healthcare Private Limited , Hyderabad,","institution_ids":[]},{"raw_affiliation_string":"Novartis Healthcare Private Limited, Hyderabad, India","institution_ids":["https://openalex.org/I4210090302"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101891047","display_name":"Rui Sun","orcid":"https://orcid.org/0000-0003-0240-8811","observed_orcids":["https://orcid.org/0000-0003-0240-8811"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rui Sun","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation , Bannockburn, IL,","Novartis Pharmaceuticals Corporation, Bannockburn, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation , Bannockburn, IL,","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, Bannockburn, IL, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105367200","display_name":"Ruvie Martin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruvie Martin","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation , East Hanover, NJ,","Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation , East Hanover, NJ,","institution_ids":[]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059317402","display_name":"Pascale Pellet","orcid":"https://orcid.org/0009-0009-1021-3361","observed_orcids":["https://orcid.org/0009-0009-1021-3361"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Pascale Pellet","raw_affiliation_strings":["Novartis Pharma AG , Basel,","Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0009-0009-1021-3361","affiliations":[{"raw_affiliation_string":"Novartis Pharma AG , Basel,","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101216845","display_name":"Thao Ngoc Phuong Huynh","orcid":"https://orcid.org/0009-0007-1043-7897","observed_orcids":["https://orcid.org/0009-0007-1043-7897"]},"institutions":[{"id":"https://openalex.org/I2802508454","display_name":"University of Medicine and Pharmacy at Ho Chi Minh City","ror":"https://ror.org/025kb2624","country_code":"VN","type":"education","lineage":["https://openalex.org/I2802508454"]},{"id":"https://openalex.org/I4210100991","display_name":"University Medical Center HCMC","ror":"https://ror.org/0154qvp54","country_code":"VN","type":"healthcare","lineage":["https://openalex.org/I4210100991"]}],"countries":["VN"],"is_corresponding":false,"raw_author_name":"Thao Ngoc Phuong Huynh","raw_affiliation_strings":["Nephrology and Hemodialysis Department, University Medical Center Ho Chi Minh City, University of Medicine and Pharmacy at Ho Chi Minh City , Ho Chi Minh City, Vietnam","University Medical Center Ho Chi Minh City, University of Medicine and Pharmacy at Ho Chi Minh City Nephrology and Hemodialysis Department, , Ho Chi Minh City, Vietnam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nephrology and Hemodialysis Department, University Medical Center Ho Chi Minh City, University of Medicine and Pharmacy at Ho Chi Minh City , Ho Chi Minh City, Vietnam","institution_ids":["https://openalex.org/I2802508454","https://openalex.org/I4210100991"]},{"raw_affiliation_string":"University Medical Center Ho Chi Minh City, University of Medicine and Pharmacy at Ho Chi Minh City Nephrology and Hemodialysis Department, , Ho Chi Minh City, Vietnam","institution_ids":["https://openalex.org/I2802508454","https://openalex.org/I4210100991"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5059317402"],"corresponding_institution_ids":["https://openalex.org/I1283582996"],"apc_list":{"value":3486,"currency":"GBP","value_usd":4597},"apc_paid":{"value":3486,"currency":"GBP","value_usd":4597},"fwci":6.2735,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.97189811,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"65","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":1.0},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.8500000238418579},{"id":"https://openalex.org/keywords/il-17a-inhibition","display_name":"IL-17A inhibition","score":0.6949999928474426},{"id":"https://openalex.org/keywords/complete-renal-response","display_name":"complete renal response","score":0.9089999794960022},{"id":"https://openalex.org/keywords/futility-analysis","display_name":"futility analysis","score":0.7369999885559082},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8840000033378601},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6845999956130981},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.6068999767303467},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.4388999938964844},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.41999998688697815},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41179999709129333},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.41110000014305115},{"id":"https://openalex.org/C2778029271","wikidata":"https://www.wikidata.org/wiki/Q5421931","display_name":"Extension (predicate logic)","level":2,"score":0.3156999945640564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29089999198913574},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.27880001068115234},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.27730000019073486},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.26109999418258667}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008181","descriptor_name":"Lupus Nephritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/rheumatology/keaf536","doi":"https://doi.org/10.1093/rheumatology/keaf536","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/keaf536","pdf_url":"https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf536/64711702/keaf536.pdf","source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11669966","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12862366","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:41092316","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41092316","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/rheumatology/keaf536","doi":"https://doi.org/10.1093/rheumatology/keaf536","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/keaf536","pdf_url":"https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keaf536/64711702/keaf536.pdf","source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415200093.pdf","grobid_xml":"https://content.openalex.org/works/W4415200093.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1989273660","https://openalex.org/W2028198473","https://openalex.org/W2083959345","https://openalex.org/W2138552777","https://openalex.org/W2298285162","https://openalex.org/W2794193200","https://openalex.org/W2794327288","https://openalex.org/W2883529004","https://openalex.org/W3014011850","https://openalex.org/W3035840352","https://openalex.org/W3198736788","https://openalex.org/W4304989906","https://openalex.org/W4322774668","https://openalex.org/W4380993043","https://openalex.org/W4386102302","https://openalex.org/W4392563982","https://openalex.org/W4394768580","https://openalex.org/W4406843312"],"related_works":["https://openalex.org/W4256088272","https://openalex.org/W2343334001","https://openalex.org/W4405388519","https://openalex.org/W2328198293","https://openalex.org/W4410513078","https://openalex.org/W4411409949","https://openalex.org/W3085025551","https://openalex.org/W1688265474","https://openalex.org/W2804557491","https://openalex.org/W2327120164"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,31,111,203],"objective":[2],"of":[3,13,21,46,86,115,122,153,163,194,199,205],"this":[4],"study":[5,33,41,89,96,118,146,270,276],"was":[6,34,119,170,209,255],"to":[7,55,100,103,227],"evaluate":[8],"the":[9,63,83,87,116,120,144,158,161,179,187,195,200,212,218,221,228,234],"efficacy":[10,246],"and":[11,189,214],"safety":[12,262],"s.c.":[14],"secukinumab":[15,57,105,154,174,188,213],"300":[16,58,106],"mg":[17,59,107],"combined":[18],"with":[19,27,48,73,251,257],"standard":[20],"care":[22],"(SoC)":[23],"in":[24,143,192,233,249],"adult":[25],"patients":[26,47,52,75,123,164,250],"active":[28,49,252],"LN.":[29,50,253],"METHODS:":[30],"core":[32,88,117,145,159,201],"a":[35,69,77,139],"phase":[36],"III":[37],"randomized,":[38],"placebo-controlled,":[39],"double-blind":[40],"(planned":[42,97],"duration:":[43,98],"104":[44],"weeks)":[45,102],"Eligible":[51],"were":[53,90,135,184,223],"randomized":[54],"receive":[56,104],"or":[60,260],"placebo":[61,180,190,215,248],"for":[62,92],"first":[64],"4":[65,109],"weeks,":[66],"followed":[67],"by":[68],"monthly":[70],"maintenance":[71],"dose,":[72],"all":[74],"receiving":[76,173,178],"SoC":[78],"background":[79],"regimen.":[80],"Patients":[81],"completing":[82],"104-week":[84],"treatment":[85],"eligible":[91],"an":[93],"open-label":[94],"extension":[95,219],"up":[99],"260":[101],"every":[108],"weeks.":[110],"primary":[112],"end":[113,197],"point":[114],"proportion":[121,162],"achieving":[124,165],"complete":[125],"renal":[126],"response":[127],"(CRR)":[128],"at":[129,167],"week":[130,168],"52.":[131],"RESULTS:":[132],"Both":[133],"studies":[134],"terminated":[136],"early,":[137],"following":[138],"planned":[140],"futility":[141],"analysis":[142,236],"that":[147],"showed":[148],"no":[149,258],"clinically":[150],"meaningful":[151],"benefit":[152],"over":[155,247],"placebo.":[156],"In":[157,217],"study,":[160,220],"CRR":[166],"52":[169],"lower":[171],"after":[172,177],"(24.2%)":[175],"than":[176],"(36.3%).":[181],"No":[182],"differences":[183],"observed":[185],"between":[186,211],"groups":[191],"any":[193],"secondary":[196],"points":[198],"study.":[202],"incidence":[204],"treatment-emergent":[206],"adverse":[207],"events":[208],"comparable":[210],"groups.":[216],"results":[222],"not":[224,243],"interpretable,":[225],"owing":[226],"low":[229],"patient":[230],"number":[231],"included":[232],"data":[235],"(n":[237],"=":[238],"31).":[239],"CONCLUSION:":[240],"Secukinumab":[241,254],"did":[242],"demonstrate":[244],"superior":[245],"well-tolerated":[256],"new":[259],"unexpected":[261],"signals":[263],"detected.":[264],"TRIAL":[265],"REGISTRATION:":[266],"https://clinicaltrials.gov/study/NCT04181762,":[267],"NCT04181762":[268],"(Novartis":[269,275],"code:":[271,277],"CAIN457Q12301).":[272],"https://www.clinicaltrials.gov/study/NCT05232864,":[273],"NCT05232864":[274],"CAIN457Q12301E1).":[278]},"counts_by_year":[{"year":2026,"cited_by_count":11}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2025-10-15T00:00:00"}